Radleys

Biotage Receives its Largest Order to Date

Date Posted: Friday, August 12, 2005

Print Email to a friend

Biotage has announced that it has received its largest single order to date. It includes 31 instruments and totals approx. 15 MSEK.

The instruments, which originate from the recently acquired company Argonaut, will be used by chemists to enhance the processes used in the development of pharmaceuticals.

"It's encouraging that we have received an order of this magnitude so soon after the acquisition of Argonaut," says Jeff Bork, president and CEO of Biotage AB.

The instruments are designed to enable the scientists to simulate a number of processes under different conditions and to move from laboratory scale to production scale. The ordered instruments will be installed at the customer's plants in the US and Europe during 2005.

"We are seeing an increased interest worldwide in the pharmaceutical industry towards tools that reduce bottlenecks for process development and full-scale production," says David Patteson, president of Biotage, Discovery Chemistry Group.

He adds, "As Medicinal Chemistry accelerates the hit-to-lead process through automation, the emphasis now moves toward getting NCEs into clinical trials."

The instruments included in the order are Advantage Series® 2410 Personal Screening Synthesizers, Advantage Series® 3400 Multi-reactor Process Chemistry Workstations and Endeavor® Parallel Catalyst-screening Instruments.

Further Information: http://www.biotage.com



Related Products

Biotage and Chemspeed Introduce Microwave Synthesis Workstation
Microwave synthesis workstation ‘SWAVE’ offers ability to fully automate the synthesis process.

Biotage Introduces the Horizon System



Related news from our archive

Biotage and Shanghai Chempartner Sign Multi-Instrument Deal
Shanghai Chempartner has invested in Biotage SP automated flash instruments and Initiator microwave synthesizers with delivery scheduled over the next 12 months.

Biotage AB and Shanghai Chempartner Sign Multi-Instrument Deal
Shanghai Chempartner has invested in Biotage automated flash instruments and Initiator microwave synthesizers with delivery scheduled over the next 12 months.

Biotage AB and McMaster University Sign Agreement to Develop new Chemistry Platform
Biotage will provide funding and instruments to the University to develop molecular imaging agents for PET and SPECT and radiotherapy agents for treatment applications.

Biotage and Shanghai Chempartner Sign Multi-Instrument Deal
Shanghai Chempartner has invested in Biotage SP automated flash instruments and Initiator microwave synthesizers with delivery scheduled over the next 12 months.

Biotage AB and Shanghai Chempartner Sign Multi-Instrument Deal
Shanghai Chempartner has invested in Biotage automated flash instruments and Initiator microwave synthesizers with delivery scheduled over the next 12 months.

Biotage AB and McMaster University Sign Agreement to Develop new Chemistry Platform
Biotage will provide funding and instruments to the University to develop molecular imaging agents for PET and SPECT and radiotherapy agents for treatment applications.

Biotage Makes a Change in Top Management after Business Area President Resigns
David Patteson, President of the business area Discovery Chemistry will leave the company on 1 April 2006.

Biotage Acquires Rights to Evaporation System from Vapourtec
Vapourtec's V-10 substantially reduces sample drying time for pharmaceutical chemists.

ProcessDevelopment.net welcomes Biotage UK, Ltd.

Biotage expands European presence